Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Ann Surg Oncol. 2011 Dec 6;19(5):1670–1677. doi: 10.1245/s10434-011-2152-y

Table 1. Reasons for censoring from cohort of patients by surveillance period.

Surveillance period from
date of surgery		 1-3 mo.
N		 % 4-9 mo.
N		 % 10-15 mo.
N		 % 16-21 mo.
N		 % 22-27 mo.
N		 %
Followed to end of period 2045 85.5 1214 59.4 741 61.0 558 75.3 452 81.0
Death 280 11.7 193 9.4 87 7.2 39 5.3 32 5.7
Recurrent disease 0 0 344 16.8 254 20.9 87 11.7 38 6.8
Enrolled in hospice 68 2.8 294 14.4 132 10.9 57 7.7 36 6.5
Total at start of period 2393 2045 1214 741 558